{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:29:37Z","timestamp":1794454177658,"version":"4.9.1"},"reference-count":111,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPR"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>The Hyper IgE Syndromes are rare primary immunodeficiencies characterized by eczema, recurrent skin and respiratory infections and elevated serum IgE levels. Nowadays a genetic-molecular characterization is possible and allows the distinction in various monogenic pathologies, which share some clinical characteristics but also important differences. In addition to long-known STAT3 and DOCK8 gene mutations, in fact, also ZNF341, CARD11, ERBB2IP, IL6R and IL6ST genes mutations can cause the disease. The main clinical manifestations are represented by newborn rash, eczema similar to atopic dermatitis, bacterial and viral skin infections, cold abscesses, respiratory infections with possible pulmonary complications, allergies, gastrointestinal manifestations, malignancies and connective tissue abnormalities. Diagnosis is still a challenge because, especially in the early stages of life, it is difficult to distinguish from other pathologies characterized by eczema and high IgE, such as atopic dermatitis. Several scores and diagnostic pathways have been developed, but it is essential to seek a genetic diagnosis. Treatment is based on prevention and early treatment of infections, meticulous skincare, intravenous immunoglobulins and HSCT, which, in some HIES subtypes, can modify the prognosis. Prognosis is related to the affected gene, but also to early diagnosis, timely treatment of infections and early HSCT.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573396320666230912103124","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T07:39:00Z","timestamp":1694590740000},"page":"253-264","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Hyper IgE Syndromes"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1530-7817","authenticated-orcid":true,"given":"Serena","family":"Gracci","sequence":"first","affiliation":[{"name":"Paediatric Unit, &#34;San Giuseppe&#34; Hospital, Empoli, Italy"},{"name":"Department of Clinical and Experimental Medicine,\nSection of Pediatrics, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0787-7810","authenticated-orcid":true,"given":"Tommaso","family":"Novelli","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine,\nSection of Pediatrics, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8440-1092","authenticated-orcid":true,"given":"Sofia","family":"D'Elios","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine,\nSection of Pediatrics, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6998-8991","authenticated-orcid":true,"given":"Roberto","family":"Bernardini","sequence":"additional","affiliation":[{"name":"Paediatric Unit, &#34;San Giuseppe&#34; Hospital, Empoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0234-1373","authenticated-orcid":true,"given":"Diego","family":"Peroni","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine,\nSection of Pediatrics, University of Pisa, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4103\/jrms.JRMS_1050_16","volume":"22","author":"Mohebbi M.","year":"2017","unstructured":"Mohebbi M.; Hashemi H.; Mehravaran S.; Mazloumi M.; Jahanbani-Ardakani H.; Abtahi S.H.; Hyperimmunoglobulin E syndrome: Genetics, immunopathogenesis, clinical findings, and treatment modalities. J Res Med Sci  2017,22(1),53","journal-title":"J Res Med Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4065\/84.1.16","volume":"84","author":"Joshi A.Y.","year":"2009","unstructured":"Joshi A.Y.; Iyer V.N.; Hagan J.B.; St Sauver J.L.; Boyce T.G.; Incidence and temporal trends of primary immunodeficiency: A population-based cohort study. Mayo Clin Proc  2009,84(1),16-22","journal-title":"Mayo Clin Proc"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0140-6736(66)90119-X","volume":"287","author":"Davis S.","year":"1966","unstructured":"Davis S.; Schaller J.; Wedgwood R.; Harvard M.D.; Job\u2019s syndrome. recurrent, \u201ccold\u201d, staphylococcal abscesses. Lancet  1966,287(7445),1013-1015","journal-title":"Lancet"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1542\/peds.49.1.59","volume":"49","author":"Buckley R.H.","year":"1972","unstructured":"Buckley R.H.; Wray B.B.; Belmaker E.Z.; Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics  1972,49(1),59-70","journal-title":"Pediatrics"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJM199903043400904","volume":"340","author":"Grimbacher B.","year":"1999","unstructured":"Grimbacher B.; Holland S.M.; Gallin J.I.; Greenberg F.; Hill S.C.; Malech H.L.; Miller J.A.; O\u2019Connell A.C.; Puck J.M.; Hyper-IgE syndrome with recurrent infections : An autosomal dominant multisystem disorder. N Engl J Med  1999,340(9),692-702","journal-title":"N Engl J Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa073687","volume":"357","author":"Holland S.M.","year":"2007","unstructured":"Holland S.M.; DeLeo F.R.; Elloumi H.Z.; Hsu A.P.; Uzel G.; Brodsky N.; Freeman A.F.; Demidowich A.; Davis J.; Turner M.L.; Anderson V.L.; Darnell D.N.; Welch P.A.; Kuhns D.B.; Frucht D.M.; Malech H.L.; Gallin J.I.; Kobayashi S.D.; Whitney A.R.; Voyich J.M.; Musser J.M.; Woellner C.; Sch\u00e4ffer A.A.; Puck J.M.; Grimbacher B.; STAT3 mutations in the hyper-IgE syndrome. N Engl J Med  2007,357(16),1608-1619","journal-title":"N Engl J Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/nature06096","volume":"448","author":"Minegishi Y.","year":"2007","unstructured":"Minegishi Y.; Saito M.; Tsuchiya S.; Tsuge I.; Takada H.; Hara T.; Kawamura N.; Ariga T.; Pasic S.; Stojkovic O.; Metin A.; Karasuyama H.; Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature  2007,448(7157),1058-1062","journal-title":"Nature"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11882-020-00964-y","volume":"20","author":"Freeman A.F.","year":"2020","unstructured":"Freeman A.F.; Milner J.D.; The child with elevated IgE and infection susceptibility. Curr Allergy Asthma Rep  2020,20(11),65","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.iac.2018.08.007","volume":"39","author":"Bergerson J.R.E.","year":"2019","unstructured":"Bergerson J.R.E.; Freeman A.F.; An update on syndromes with a Hyper-IgE phenotype. Immunol Allergy Clin North Am  2019,39(1),49-61","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","volume":"91","author":"Chandesris M.O.","year":"2012","unstructured":"Chandesris M.O.; Melki I.; Natividad A.; Puel A.; Fieschi C.; Yun L.; Thumerelle C.; Oksenhendler E.; Boutboul D.; Thomas C.; Hoarau C.; Lebranchu Y.; Stephan J.L.; Cazorla C.; Aladjidi N.; Micheau M.; Tron F.; Baruchel A.; Barlogis V.; Palenzuela G.; Mathey C.; Dominique S.; Body G.; Munzer M.; Fouyssac F.; Jaussaud R.; Bader-Meunier B.; Mahlaoui N.; Blanche S.; Debr\u00e9 M.; Le Bourgeois M.; Gandemer V.; Lambert N.; Grandin V.; Ndaga S.; Jacques C.; Harre C.; Forveille M.; Alyanakian M.A.; Durandy A.; Bodemer C.; Suarez F.; Hermine O.; Lortholary O.; Casanova J.L.; Fischer A.; Picard C.; Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: Molecular, cellular, and clinical features from a French national survey. Medicine  2012,91(4),e1-e19","journal-title":"Medicine"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12016-009-8134-1","volume":"38","author":"Heimall J.","year":"2010","unstructured":"Heimall J.; Freeman A.; Holland S.M.; Pathogenesis of hyper IgE syndrome. Clin Rev Allergy Immunol  2010,38(1),32-38","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jaci.2008.04.037","volume":"122","author":"Renner E.D.","year":"2008","unstructured":"Renner E.D.; Rylaarsdam S.; A\u0148over-Sombke S.; Rack A.L.; Reichenbach J.; Carey J.C.; Zhu Q.; Jansson A.F.; Barboza J.; Schimke L.F.; Leppert M.F.; Getz M.M.; Seger R.A.; Hill H.R.; Belohradsky B.H.; Torgerson T.R.; Ochs H.D.; Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced TH17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol  2008,122(1),181-187","journal-title":"J Allergy Clin Immunol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1084\/jem.20061308","volume":"203","author":"Liang S.C.","year":"2006","unstructured":"Liang S.C.; Tan X.Y.; Luxenberg D.P.; Karim R.; Dunussi-Joannopoulos K.; Collins M.; Fouser L.A.; Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med  2006,203(10),2271-2279","journal-title":"J Exp Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nm1710","volume":"14","author":"Aujla S.J.","year":"2008","unstructured":"Aujla S.J.; Chan Y.R.; Zheng M.; Fei M.; Askew D.J.; Pociask D.A.; Reinhart T.A.; McAllister F.; Edeal J.; Gaus K.; Husain S.; Kreindler J.L.; Dubin P.J.; Pilewski J.M.; Myerburg M.M.; Mason C.A.; Iwakura Y.; Kolls J.K.; IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med  2008,14(3),275-281","journal-title":"Nat Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1086\/422329","volume":"190","author":"Huang W.","year":"2004","unstructured":"Huang W.; Na L.; Fidel P.L.; Schwarzenberger P.; Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis  2004,190(3),624-631","journal-title":"J Infect Dis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.4049\/jimmunol.173.5.3482","volume":"173","author":"Kao C.Y.","year":"2004","unstructured":"Kao C.Y.; Chen Y.; Thai P.; Wachi S.; Huang F.; Kim C.; Harper R.W.; Wu R.; IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol  2004,173(5),3482-3491","journal-title":"J Immunol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","volume":"4i1","author":"Crotty S.","year":"2014","unstructured":"Crotty S.; T follicular helper cell differentiation, function, and roles in disease. Immunity  2014,4i1(4),529-542","journal-title":"Immunity"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1365-2567.2006.02321.x","volume":"117","author":"Taylor A.","year":"2006","unstructured":"Taylor A.; Verhagen J.; Blaser K.; Akdis M.; Akdis C.A.; Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: The role of T regulatory cells. Immunology  2006,117(4),433-442","journal-title":"Immunology"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.4049\/jimmunol.179.9.5886","volume":"179","author":"Kuchen S.","year":"2007","unstructured":"Kuchen S.; Robbins R.; Sims G.P.; Sheng C.; Phillips T.M.; Lipsky P.E.; Ettinger R.; Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol  2007,179(9),5886-5896","journal-title":"J Immunol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.jaci.2011.07.046","volume":"128","author":"Sekhsaria V.","year":"2011","unstructured":"Sekhsaria V.; Dodd L.E.; Hsu A.P.; Heimall J.R.; Freeman A.F.; Ding L.; Holland S.M.; Uzel G.; Plasma metalloproteinase levels are dysregulated in signal transducer and activator of transcription 3 mutated hyper-IgE syndrome. J Allergy Clin Immunol  2011,128(5),1124-1127","journal-title":"J Allergy Clin Immunol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ajhg.2011.05.024","volume":"89","author":"Nieminen P.","year":"2011","unstructured":"Nieminen P.; Morgan N.V.; Fenwick A.L.; Parmanen S.; Veistinen L.; Mikkola M.L.; van der Spek P.J.; Giraud A.; Judd L.; Arte S.; Brueton L.A.; Wall S.A.; Mathijssen I.M.J.; Maher E.R.; Wilkie A.O.M.; Kreiborg S.; Thesleff I.; Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth. Am J Hum Genet  2011,89(1),67-81","journal-title":"Am J Hum Genet"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jaip.2017.06.041","volume":"6","author":"Gernez Y.","year":"2018","unstructured":"Gernez Y.; Freeman A.F.; Holland S.M.; Garabedian E.; Patel N.C.; Puck J.M.; Sullivan K.E.; Akhter J.; Secord E.; Chen K.; Buckley R.; Haddad E.; Ochs H.D.; Fuleihan R.; Routes J.; Muskat M.; Lugar P.; Mancini J.; Cunningham-Rundles C.; Autosomal dominant hyper-IgE syndrome in the USIDNET registry. J Allergy Clin Immunol Pract  2018,6(3),996-1001","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"16463","DOI":"10.1073\/pnas.1901409116","volume":"116","author":"Khourieh J.","year":"2019","unstructured":"Khourieh J.; Rao G.; Habib T.; Avery D.T.; Lef\u00e8vre-Utile A.; Chandesris M.O.; Belkadi A.; Chrabieh M.; Alwaseem H.; Grandin V.; Sarrot-Reynauld F.; S\u00e9n\u00e9chal A.; Lortholary O.; Kong X.F.; Boisson-Dupuis S.; Picard C.; Puel A.; B\u00e9ziat V.; Zhang Q.; Abel L.; Molina H.; Marr N.; Tangye S.G.; Casanova J.L.; Boisson B.; A deep intronic splice mutation of STAT3 underlies hyper IgE syndrome by negative dominance. Proc Natl Acad Sci  2019,116(33),16463-16472","journal-title":"Proc Natl Acad Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.clim.2011.01.001","volume":"139","author":"Heimall J.","year":"2011","unstructured":"Heimall J.; Davis J.; Shaw P.A.; Hsu A.P.; Gu W.; Welch P.; Holland S.M.; Freeman A.F.; Paucity of genotype\u2013phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES). Clin Immunol  2011,139(1),75-84","journal-title":"Clin Immunol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1084\/jem.20161435","volume":"214","author":"Lyons J.J.","year":"2017","unstructured":"Lyons J.J.; Liu Y.; Ma C.A.; Yu X.; O\u2019Connell M.P.; Lawrence M.G.; Zhang Y.; Karpe K.; Zhao M.; Siegel A.M.; Stone K.D.; Nelson C.; Jones N.; DiMaggio T.; Darnell D.N.; Mendoza-Caamal E.; Orozco L.; Hughes J.D.; McElwee J.; Hohman R.J.; Frischmeyer-Guerrerio P.A.; Rothenberg M.E.; Freeman A.F.; Holland S.M.; Milner J.D.; ERBIN deficiency links STAT3 and TGF-\u03b2 pathway defects with atopy in humans. J Exp Med  2017,214(3),669-680","journal-title":"J Exp Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2174\/138920310794557673","volume":"11","author":"Liu D.","year":"2010","unstructured":"Liu D.; Shi M.; Duan H.; Han C.; Guo N.; Erbin, a negative regulator in diverse signal pathways. Curr Protein Pept Sci  2010,11(8),759-764","journal-title":"Curr Protein Pept Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/ng.3898","volume":"49","author":"Ma C.A.","year":"2017","unstructured":"Ma C.A.; Stinson J.R.; Zhang Y.; Abbott J.K.; Weinreich M.A.; Hauk P.J.; Reynolds P.R.; Lyons J.J.; Nelson C.G.; Ruffo E.; Dorjbal B.; Glauzy S.; Yamakawa N.; Arjunaraja S.; Voss K.; Stoddard J.; Niemela J.; Zhang Y.; Rosenzweig S.D.; McElwee J.J.; DiMaggio T.; Matthews H.F.; Jones N.; Stone K.D.; Palma A.; Oleastro M.; Prieto E.; Bernasconi A.R.; Dubra G.; Danielian S.; Zaiat J.; Marti M.A.; Kim B.; Cooper M.A.; Romberg N.; Meffre E.; Gelfand E.W.; Snow A.L.; Milner J.D.; Germline hypomorphic CARD11 mutations in severe atopic disease. Nat Genet  2017,49(8),1192-1201","journal-title":"Nat Genet"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.jaci.2017.06.047","volume":"141","author":"Dadi H.","year":"2018","unstructured":"Dadi H.; Jones T.A.; Merico D.; Sharfe N.; Ovadia A.; Schejter Y.; Reid B.; Sun M.; Vong L.; Atkinson A.; Lavi S.; Pomerantz J.L.; Roifman C.M.; Combined immunodeficiency and atopy caused by a dominant negative mutation in caspase activation and recruitment domain family member 11 (CARD11). J Allergy Clin Immunol  2018,141(5),1818-1830.e2","journal-title":"J Allergy Clin Immunol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jaci.2010.12.1081","volume":"127","author":"Altin J.A.","year":"2011","unstructured":"Altin J.A.; Tian L.; Liston A.; Bertram E.M.; Goodnow C.C.; Cook M.C.; Decreased T-cell receptor signaling through CARD11 differentially compromises forkhead box protein 3\u2013positive regulatory versus TH2 effector cells to cause allergy. J Allergy Clin Immunol  2011,127(5),1277-1285.e5","journal-title":"J Allergy Clin Immunol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jaci.2009.10.038","volume":"124","author":"Engelhardt K.R.","year":"2009","unstructured":"Engelhardt K.R.; McGhee S.; Winkler S.; Sassi A.; Woellner C.; Lopez-Herrera G.; Chen A.; Kim H.S.; Lloret M.G.; Schulze I.; Ehl S.; Thiel J.; Pfeifer D.; Veelken H.; Niehues T.; Siepermann K.; Weinspach S.; Reisli I.; Keles S.; Genel F.; Kutuculer N.; Camc\u0131o\u011flu Y.; Somer A.; Karakoc-Aydiner E.; Barlan I.; Gennery A.; Metin A.; Degerliyurt A.; Pietrogrande M.C.; Yeganeh M.; Baz Z.; Al-Tamemi S.; Klein C.; Puck J.M.; Holland S.M.; McCabe E.R.B.; Grimbacher B.; Chatila T.A.; Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol  2009,124(6),1289-1302.e4","journal-title":"J Allergy Clin Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0022-3476(03)00449-9","volume":"144","author":"Renner E.D.","year":"2004","unstructured":"Renner E.D.; Puck J.M.; Holland S.M.; Schmitt M.; Weiss M.; Frosch M.; Bergmann M.; Davis J.; Belohradsky B.H.; Grimbacher B.; Autosomal recessive hyperimmunoglobulin E syndrome: A distinct disease entity. J Pediatr  2004,144(1),93-99","journal-title":"J Pediatr"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1242\/jcs.02671","volume":"118","author":"Meller N.","year":"2005","unstructured":"Meller N.; Merlot S.; Guda C.; CZH proteins: A new family of Rho-GEFs. J Cell Sci  2005,118(21),4937-4946","journal-title":"J Cell Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/cmi.2017.9","volume":"14","author":"Kearney C.J.","year":"2017","unstructured":"Kearney C.J.; Randall K.L.; Oliaro J.; DOCK8 regulates signal transduction events to control immunity. Cell Mol Immunol  2017,14(5),406-411","journal-title":"Cell Mol Immunol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1182\/blood-2012-01-407098","volume":"119","author":"Harada Y.","year":"2012","unstructured":"Harada Y.; Tanaka Y.; Terasawa M.; Pieczyk M.; Habiro K.; Katakai T.; Hanawa-Suetsugu K.; Kukimoto-Niino M.; Nishizaki T.; Shirouzu M.; Duan X.; Uruno T.; Nishikimi A.; Sanematsu F.; Yokoyama S.; Stein J.V.; Kinashi T.; Fukui Y.; DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood  2012,119(19),4451-4461","journal-title":"Blood"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jaci.2016.07.016","volume":"139","author":"Tangye S.G.","year":"2017","unstructured":"Tangye S.G.; Pillay B.; Randall K.L.; Avery D.T.; Phan T.G.; Gray P.; Ziegler J.B.; Smart J.M.; Peake J.; Arkwright P.D.; Hambleton S.; Orange J.; Goodnow C.C.; Uzel G.; Casanova J.L.; Lugo Reyes S.O.; Freeman A.F.; Su H.C.; Ma C.S.; Dedicator of cytokinesis 8\u2013deficient CD4 T cells are biased to a T 2 effector fate at the expense of T 1 and T 17 cells. J Allergy Clin Immunol  2017,139(3),933-949","journal-title":"J Allergy Clin Immunol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"e94275","DOI":"10.1172\/jci.insight.94275","volume":"2","author":"Singh A.K.","year":"2017","unstructured":"Singh A.K.; Eken A.; Hagin D.; Komal K.; Bhise G.; Shaji A.; Arkatkar T.; Jackson S.W.; Bettelli E.; Torgerson T.R.; Oukka M.; DOCK8 regulates fitness and function of regulatory T cells through modulation of IL-2 signaling. JCI Insight  2017,2(19),e94275","journal-title":"JCI Insight"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1084\/jem.20110345","volume":"208","author":"Randall K.L.","year":"2011","unstructured":"Randall K.L.; Chan S.S.Y.; Ma C.S.; Fung I.; Mei Y.; Yabas M.; Tan A.; Arkwright P.D.; Al Suwairi W.; Lugo Reyes S.O.; Yamazaki-Nakashimada M.A.; de la Luz Garcia-Cruz M.; Smart J.M.; Picard C.; Okada S.; Jouanguy E.; Casanova J.L.; Lambe T.; Cornall R.J.; Russell S.; Oliaro J.; Tangye S.G.; Bertram E.M.; Goodnow C.C.; DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med  2011,208(11),2305-2320","journal-title":"J Exp Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1084\/jem.20141307","volume":"211","author":"Zhang Q.","year":"2014","unstructured":"Zhang Q.; Dove C.G.; Hor J.L.; Murdock H.M.; Strauss-Albee D.M.; Garcia J.A.; Mandl J.N.; Grodick R.A.; Jing H.; Chandler-Brown D.B.; Lenardo T.E.; Crawford G.; Matthews H.F.; Freeman A.F.; Cornall R.J.; Germain R.N.; Mueller S.N.; Su H.C.; DOCK8 regulates lymphocyte shape integrity for skin antiviral immunity. J Exp Med  2014,211(13),2549-2566","journal-title":"J Exp Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.4049\/jimmunol.1202792","volume":"190","author":"Ham H.","year":"2013","unstructured":"Ham H.; Guerrier S.; Kim J.; Schoon R.A.; Anderson E.L.; Hamann M.J.; Lou Z.; Billadeau D.D.; Dedicator of cytokinesis 8 interacts with talin and Wiskott-Aldrich syndrome protein to regulate NK cell cytotoxicity. J Immunol  2013,190(7),3661-3669","journal-title":"J Immunol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/ni.1820","volume":"10","author":"Randall K.L.","year":"2009","unstructured":"Randall K.L.; Lambe T.; Johnson A.L.; Treanor B.; Kucharska E.; Domaschenz H.; Whittle B.; Tze L.E.; Enders A.; Crockford T.L.; Bouriez-Jones T.; Alston D.; Cyster J.G.; Lenardo M.J.; Mackay F.; Deenick E.K.; Tangye S.G.; Chan T.D.; Camidge T.; Brink R.; Vinuesa C.G.; Batista F.D.; Cornall R.J.; Goodnow C.C.; Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production. Nat Immunol  2009,10(12),1283-1291","journal-title":"Nat Immunol"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jaci.2014.02.025","volume":"133","author":"Sassi A","year":"2014","unstructured":"Sassi A; Lazaroski S; Wu G; Haslam SM; Fliegauf M; Mellouli F; Patiroglu T; Unal E; Ozdemir MA; Jouhadi Z; Khadir K; Ben-Khemis L; Ben-Ali M; Ben-Mustapha I; Borchani L; Pfeifer D; Jakob T; Khemiri M; Asplund AC; Gustafsson MO; Lundin KE; Falk-S\u00f6rqvist E; Moens LN; Gungor HE; Engelhardt KR; Dziadzio M; Stauss H; Fleckenstein B; Meier R; Prayitno K; Maul-Pavicic A; Schaffer S; Rakhmanov M; Henneke P; Kraus H; Eibel H; K\u00f6lsch U; Nadifi S; Nilsson M; Bejaoui M; Sch\u00e4ffer AA; Smith CI; Dell A; Barbouche MR; Grimbacher B; Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. J Allergy Clin Immunol  2014,133(5),1410-9.e1-13","journal-title":"J Allergy Clin Immunol"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jaci.2014.02.013","volume":"133","author":"Zhang Y","year":"2014","unstructured":"Zhang Y; Yu X; Ichikawa M; Lyons JJ; Datta S; Lamborn IT; Jing H; Kim ES; Biancalana M; Wolfe LA; DiMaggio T; Matthews HF; Kranick SM; Stone KD; Holland SM; Reich DS; Hughes JD; Mehmet H; McElwee J; Freeman AF; Freeze HH; Su HC; Milner JD; Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol  2014,133(5),1400-1409","journal-title":"J Allergy Clin Immunol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/jimd.12126","volume":"43","author":"Pascoal C.","year":"2020","unstructured":"Pascoal C.; Francisco R.; Ferro T.; dos Reis Ferreira V.; Jaeken J.; Videira P.A.; CDG and immune response: From bedside to bench and back. J Inherit Metab Dis  2020,43(1),90-124","journal-title":"J Inherit Metab Dis"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/imcb.12209","volume":"97","author":"Al-Shaikhly T.","year":"2019","unstructured":"Al-Shaikhly T.; Ochs H.D.; Hyper IgE syndromes: Clinical and molecular characteristics. Immunol Cell Biol  2019,97(4),368-379","journal-title":"Immunol Cell Biol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/MOP.0000000000000158","volume":"26","author":"Yang L.","year":"2014","unstructured":"Yang L.; Fliegauf M.; Grimbacher B.; Hyper-IgE syndromes. Curr Opin Pediatr  2014,26(6),697-703","journal-title":"Curr Opin Pediatr"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"eaat4941","DOI":"10.1126\/sciimmunol.aat4941","volume":"3","author":"Frey-Jakobs S.","year":"2018","unstructured":"Frey-Jakobs S.; Hartberger J.M.; Fliegauf M.; Bossen C.; Wehmeyer M.L.; Neubauer J.C.; Bulashevska A.; Proietti M.; Fr\u00f6bel P.; N\u00f6ltner C.; Yang L.; Rojas-Restrepo J.; Langer N.; Winzer S.; Engelhardt K.R.; Glocker C.; Pfeifer D.; Klein A.; Sch\u00e4ffer A.A.; Lagovsky I.; Lachover-Roth I.; B\u00e9ziat V.; Puel A.; Casanova J.L.; Fleckenstein B.; Weidinger S.; Kilic S.S.; Garty B.Z.; Etzioni A.; Grimbacher B.; ZNF341 controls STAT3 expression and thereby immunocompetence. Sci Immunol  2018,3(24),eaat4941","journal-title":"Sci Immunol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"eaat4956","DOI":"10.1126\/sciimmunol.aat4956","volume":"3","author":"B\u00e9ziat V.","year":"2018","unstructured":"B\u00e9ziat V.; Li J.; Lin J.X.; Ma C.S.; Li P.; Bousfiha A.; Pellier I.; Zoghi S.; Baris S.; Keles S.; Gray P.; Du N.; Wang Y.; Zerbib Y.; L\u00e9vy R.; Leclercq T.; About F.; Lim A.I.; Rao G.; Payne K.; Pelham S.J.; Avery D.T.; Deenick E.K.; Pillay B.; Chou J.; Guery R.; Belkadi A.; Gu\u00e9rin A.; Migaud M.; Rattina V.; Ailal F.; Benhsaien I.; Bouaziz M.; Habib T.; Chaussabel D.; Marr N.; El-Benna J.; Grimbacher B.; Wargon O.; Bustamante J.; Boisson B.; M\u00fcller-Fleckenstein I.; Fleckenstein B.; Chandesris M.O.; Titeux M.; Fraitag S.; Alyanakian M.A.; Leruez-Ville M.; Picard C.; Meyts I.; Di Santo J.P.; Hovnanian A.; Somer A.; Ozen A.; Rezaei N.; Chatila T.A.; Abel L.; Leonard W.J.; Tangye S.G.; Puel A.; Casanova J.L.; A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity. Sci Immunol  2018,3(24),eaat4956","journal-title":"Sci Immunol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"a028415","DOI":"10.1101\/cshperspect.a028415","volume":"10","author":"Rose-John S.","year":"2018","unstructured":"Rose-John S.; Interleukin-6 family cytokines. Cold Spring Harb Perspect Biol  2018,10(2),a028415","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2019.03.027","volume":"50","author":"Murakami M.","year":"2019","unstructured":"Murakami M.; Kamimura D.; Hirano T.; Pleiotropy and specificity: Insights from the interleukin 6 family of cytokines. Immunity  2019,50(4),812-831","journal-title":"Immunity"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.jaci.2021.02.044","volume":"148","author":"Chen Y.H.","year":"2021","unstructured":"Chen Y.H.; Zastrow D.B.; Metcalfe R.D.; Gartner L.; Krause F.; Morton C.J.; Marwaha S.; Fresard L.; Huang Y.; Zhao C.; McCormack C.; Bick D.; Worthey E.A.; Eng C.M.; Gold J.; Montgomery S.B.; Fisher P.G.; Ashley E.A.; Wheeler M.T.; Parker M.W.; Shanmugasundaram V.; Putoczki T.L.; Schmidt-Arras D.; Laurence A.; Bernstein J.A.; Griffin M.D.W.; Uhlig H.H.; Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndrome. J Allergy Clin Immunol  2021,148(2),585-598","journal-title":"J Allergy Clin Immunol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"e20191804","DOI":"10.1084\/jem.20191804","volume":"217","author":"B\u00e9ziat V.","year":"2020","unstructured":"B\u00e9ziat V.; Tavernier S.J.; Chen Y.H.; Ma C.S.; Materna M.; Laurence A.; Staal J.; Aschenbrenner D.; Roels L.; Worley L.; Claes K.; Gartner L.; Kohn L.A.; De Bruyne M.; Schmitz-Abe K.; Charbonnier L.M.; Keles S.; Nammour J.; Vladikine N.; Maglorius Renkilaraj M.R.L.; Seeleuthner Y.; Migaud M.; Rosain J.; Jeljeli M.; Boisson B.; Van Braeckel E.; Rosenfeld J.A.; Dai H.; Burrage L.C.; Murdock D.R.; Lambrecht B.N.; Avettand-Fenoel V.; Vogel T.P.; Esther C.R.; Haskologlu S.; Dogu F.; Ciznar P.; Boutboul D.; Ouach\u00e9e-Chardin M.; Amourette J.; Lebras M.N.; Gauvain C.; Tcherakian C.; Ikinciogullari A.; Beyaert R.; Abel L.; Milner J.D.; Grimbacher B.; Couderc L.J.; Butte M.J.; Freeman A.F.; Catherinot \u00c9.; Fieschi C.; Chatila T.A.; Tangye S.G.; Uhlig H.H.; Haerynck F.; Casanova J.L.; Puel A.; Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med  2020,217(6),e20191804","journal-title":"J Exp Med"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1084\/jem.20190344","volume":"216","author":"Spencer S.","year":"2019","unstructured":"Spencer S.; K\u00f6stel Bal S.; Egner W.; Lango Allen H.; Raza S.I.; Ma C.A.; G\u00fcrel M.; Zhang Y.; Sun G.; Sabroe R.A.; Greene D.; Rae W.; Shahin T.; Kania K.; Ardy R.C.; Thian M.; Staples E.; Pecchia-Bekkum A.; Worrall W.P.M.; Stephens J.; Brown M.; Tuna S.; York M.; Shackley F.; Kerrin D.; Sargur R.; Condliffe A.; Tipu H.N.; Kuehn H.S.; Rosenzweig S.D.; Turro E.; Tavar\u00e9 S.; Thrasher A.J.; Jodrell D.I.; Smith K.G.C.; Boztug K.; Milner J.D.; Thaventhiran J.E.D.; Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses. J Exp Med  2019,216(9),1986-1998","journal-title":"J Exp Med"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1146\/annurev.immunol.15.1.797","volume":"15","author":"Taga T.","year":"1997","unstructured":"Taga T.; Kishimoto T.;  130 and the interleukin-6 family of cytokines. Annu Rev Immunol  1997,15(1),797-819","journal-title":"Annu Rev Immunol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1086\/302547","volume":"65","author":"Grimbacher B.","year":"1999","unstructured":"Grimbacher B.; Sch\u00e4ffer A.A.; Holland S.M.; Davis J.; Gallin J.I.; Malech H.L.; Atkinson T.P.; Belohradsky B.H.; Buckley R.H.; Cossu F.; Espa\u00f1ol T.; Garty B.Z.; Matamoros N.; Myers L.A.; Nelson R.P.; Ochs H.D.; Renner E.D.; Wellinghausen N.; Puck J.M.; Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet  1999,65(3),735-744","journal-title":"Am J Hum Genet"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/archderm.140.9.1119","volume":"140","author":"Eberting C.L.D.","year":"2004","unstructured":"Eberting C.L.D.; Davis J.; Puck J.M.; Holland S.M.; Turner M.L.; Dermatitis and the newborn rash of hyper-IgE syndrome. Arch Dermatol  2004,140(9),1119-1125","journal-title":"Arch Dermatol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2332\/allergolint.12-RAI-0423","volume":"61","author":"Minegishi Y.","year":"2012","unstructured":"Minegishi Y.; Saito M.; Cutaneous manifestations of Hyper IgE syndrome. Allergol Int  2012,61(2),191-196","journal-title":"Allergol Int"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0190-9622(92)70156-A","volume":"27","author":"Ta\u00efeb A.","year":"1992","unstructured":"Ta\u00efeb A.; Bassan-Andrieu L.; Maleville J.; Eosinophilic pustulosis of the scalp in childhood. J Am Acad Dermatol  1992,27(1),55-60","journal-title":"J Am Acad Dermatol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1525-1470.1984.tb01116.x","volume":"1","author":"Lucky A.W.","year":"1984","unstructured":"Lucky A.W.; Esterly N.; Heskel N.; Krafchik B.R.; Solomon L.M.; Eosinophilic pustular folliculitis in infancy. Pediatr Dermatol  1984,1(3),202-206","journal-title":"Pediatr Dermatol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1067\/mpd.2002.127503","volume":"141","author":"Chamlin S.L.","year":"2002","unstructured":"Chamlin S.L.; McCalmont T.H.; Cunningham B.B.; Esterly N.B.; Lai C.H.; Mallory S.B.; Mancini A.J.; Tamburro J.; Frieden I.J.; Cutaneous manifestations of hyper-IgE syndrome in infants and children. J Pediatr  2002,141(4),572-575","journal-title":"J Pediatr"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000247728","volume":"182","author":"Hochreutener H.","year":"1991","unstructured":"Hochreutener H.; W\u00fcthrich B.; Huwyler T.; Schopfer K.; Seger R.; Baerlocher K.; Variant of hyper-IgE syndrome: The differentiation from atopic dermatitis is important because of treatment and prognosis. Dermatology  1991,182(1),7-11","journal-title":"Dermatology"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11882-018-0806-6","volume":"18","author":"Wu J.","year":"2018","unstructured":"Wu J.; Hong L.; Chen T.X.; Clinical manifestation of hyper IgE syndrome including otitis media. Curr Allergy Asthma Rep  2018,18(10),51","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/pathogens6020023","volume":"6","author":"Sastalla I.","year":"2017","unstructured":"Sastalla I.; Williams K.; Anderson E.; Myles I.; Reckhow J.; Espinoza-Moraga M.; Freeman A.; Datta S.; Molecular typing of staphylococcus aureus isolated from patients with autosomal dominant hyper IgE syndrome. Pathogens  2017,6(2),23","journal-title":"Pathogens"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.tim.2017.11.008","volume":"26","author":"Geoghegan J.A.","year":"2018","unstructured":"Geoghegan J.A.; Irvine A.D.; Foster T.J.; Staphylococcus aureus and atopic dermatitis: A complex and evolving relationship. Trends Microbiol  2018,26(6),484-497","journal-title":"Trends Microbiol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.3390\/ijms21239152","volume":"21","author":"Park B.","year":"2020","unstructured":"Park B.; Liu G.Y.; Staphylococcus aureus and hyper-IgE syndrome. Int J Mol Sci  2020,21(23),9152","journal-title":"Int J Mol Sci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1084\/jem.20082767","volume":"206","author":"Minegishi Y.","year":"2009","unstructured":"Minegishi Y.; Saito M.; Nagasawa M.; Takada H.; Hara T.; Tsuchiya S.; Agematsu K.; Yamada M.; Kawamura N.; Ariga T.; Tsuge I.; Karasuyama H.; Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med  2009,206(6),1291-1301","journal-title":"J Exp Med"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1126\/science.1200439","volume":"332","author":"Puel A.","year":"2011","unstructured":"Puel A.; Cypowyj S.; Bustamante J.; Wright J.F.; Liu L.; Lim H.K.; Migaud M.; Israel L.; Chrabieh M.; Audry M.; Gumbleton M.; Toulon A.; Bodemer C.; El-Baghdadi J.; Whitters M.; Paradis T.; Brooks J.; Collins M.; Wolfman N.M.; Al-Muhsen S.; Galicchio M.; Abel L.; Picard C.; Casanova J.L.; Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science  2011,332(6025),65-68","journal-title":"Science"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/mi.2011.5","volume":"4","author":"Conti H.R.","year":"2011","unstructured":"Conti H.R.; Baker O.; Freeman A.F.; Jang W.S.; Holland S.M.; Li R.A.; Edgerton M.; Gaffen S.L.; New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome. Mucosal Immunol  2011,4(4),448-455","journal-title":"Mucosal Immunol"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jaci.2015.07.003","volume":"136","author":"Odio CD","year":"2015","unstructured":"Odio CD; Milligan KL; McGowan K; Rudman Spergel AK; Bishop R; Boris L; Urban A; Welch P; Heller T; Kleiner D; Jackson MA; Holland SM; Freeman AF; Endemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndrome. J Allergy Clin Immunol  2015,136(5),1411-1413","journal-title":"J Allergy Clin Immunol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/archdermatol.2011.262","volume":"148","author":"Chu E.Y.","year":"2012","unstructured":"Chu E.Y.; Freeman A.F.; Jing H.; Cowen E.W.; Davis J.; Su H.C.; Holland S.M.; Turner M.L.; Cutaneous manifestations of DOCK8 deficiency syndrome. Arch Dermatol  2012,148(1),79-84","journal-title":"Arch Dermatol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ccm.2016.04.016","volume":"37","author":"Freeman A.F.","year":"2016","unstructured":"Freeman A.F.; Olivier K.N.; Hyper-IgE syndromes and the lung. Clin Chest Med  2016,37(3),557-567","journal-title":"Clin Chest Med"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jaci.2006.12.666","volume":"119","author":"Freeman A.F.","year":"2007","unstructured":"Freeman A.F.; Kleiner D.E.; Nadiminti H.; Davis J.; Quezado M.; Anderson V.; Puck J.M.; Holland S.M.; Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol  2007,119(5),1234-1240","journal-title":"J Allergy Clin Immunol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.jaci.2010.01.047","volume":"125","author":"Vinh D.C.","year":"2010","unstructured":"Vinh D.C.; Sugui J.A.; Hsu A.P.; Freeman A.F.; Holland S.M.; Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J Allergy Clin Immunol  2010,125(6),1389-1390","journal-title":"J Allergy Clin Immunol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jaci.2009.07.007","volume":"124","author":"Melia E.","year":"2009","unstructured":"Melia E.; Freeman A.F.; Shea Y.R.; Hsu A.P.; Holland S.M.; Olivier K.N.; Pulmonary nontuberculous mycobacterial infections in hyper-IgE syndrome. J Allergy Clin Immunol  2009,124(3),617-618","journal-title":"J Allergy Clin Immunol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4103\/0301-4738.55076","volume":"57","author":"Kim U.R.","year":"2009","unstructured":"Kim U.R.; Arora V.; Khazei H.; Kusagur S.; Ophthalmic complications including retinal detachment in hyperimmunoglobulinemia E (Job\u2032s) syndrome: Case report and review of literature. Indian J Ophthalmol  2009,57(5),385-386","journal-title":"Indian J Ophthalmol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/all.12416","volume":"69","author":"Boos A.C.","year":"2014","unstructured":"Boos A.C.; Hagl B.; Schlesinger A.; Halm B.E.; Ballenberger N.; Pinarci M.; Heinz V.; Kreilinger D.; Spielberger B.D.; Schimke-Marques L.F.; Sawalle-Belohradsky J.; Belohradsky B.H.; Przybilla B.; Schaub B.; Wollenberg A.; Renner E.D.; Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern. Allergy  2014,69(7),943-953","journal-title":"Allergy"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3109\/07853890.2014.882105","volume":"46","author":"Rajala H.L.M.","year":"2014","unstructured":"Rajala H.L.M.; Porkka K.; Maciejewski J.P.; Loughran T.P.; Mustjoki S.; Uncovering the pathogenesis of large granular lymphocytic leukemia\u2014novel STAT3 and STAT5b mutations. Ann Med  2014,46(3),114-122","journal-title":"Ann Med"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10875-014-0126-0","volume":"35","author":"Aydin S.E.","year":"2015","unstructured":"Aydin S.E.; Kilic S.S.; Aytekin C.; Kumar A.; Porras O.; Kainulainen L.; Kostyuchenko L.; Genel F.; K\u00fct\u00fckc\u00fcler N.; Karaca N.; Gonzalez-Granado L.; Abbott J.; Al-Zahrani D.; Rezaei N.; Baz Z.; Thiel J.; Ehl S.; Marodi L.; Orange J.S.; Sawalle-Belohradsky J.; Keles S.; Holland S.M.; Sanal \u00d6.; Ayvaz D.C.; Tezcan I.; Al-Mousa H.; Alsum Z.; Hawwari A.; Metin A.; Matthes-Martin S.; H\u00f6nig M.; Schulz A.; Picard C.; Barlogis V.; Gennery A.; Ifversen M.; van Montfrans J.; Kuijpers T.; Bredius R.; D\u00fcckers G.; Al-Herz W.; Pai S.Y.; Geha R.; Notheis G.; Schwarze C.P.; Tavil B.; Azik F.; Bienemann K.; Grimbacher B.; Heinz V.; Gaspar H.B.; Aydin R.; Hagl B.; Gathmann B.; Belohradsky B.H.; Ochs H.D.; Chatila T.; Renner E.D.; Su H.; Freeman A.F.; Engelhardt K.; Albert M.H.; DOCK8 deficiency: Clinical and immunological phenotype and treatment options : A review of 136 patients. J Clin Immunol  2015,35(2),189-198","journal-title":"J Clin Immunol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s10875-013-9982-2","volume":"34","author":"Sowerwine K.J.","year":"2014","unstructured":"Sowerwine K.J.; Shaw P.A.; Gu W.; Ling J.C.; Collins M.T.; Darnell D.N.; Anderson V.L.; Davis J.; Hsu A.; Welch P.; Puck J.M.; Holland S.M.; Freeman A.F.; Bone density and fractures in autosomal dominant hyper IgE syndrome. J Clin Immunol  2014,34(2),260-264","journal-title":"J Clin Immunol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s10875-020-00926-z","volume":"41","author":"Mitchell A.L.","year":"2021","unstructured":"Mitchell A.L.; Urban A.K.; Freeman A.F.; Hammoud D.A.; An unusual pattern of premature cervical spine degeneration in STAT3-LOF. J Clin Immunol  2021,41(3),576-584","journal-title":"J Clin Immunol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13023-020-01516-3","volume":"15","author":"Meixner I.","year":"2020","unstructured":"Meixner I.; Hagl B.; Kr\u00f6ner C.I.; Spielberger B.D.; Paschos E.; D\u00fcckers G.; Niehues T.; Hesse R.; Renner E.D.; Retained primary teeth in STAT3 hyper-IgE syndrome: early intervention in childhood is essential. Orphanet J Rare Dis  2020,15(1),244","journal-title":"Orphanet J Rare Dis"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s10875-011-9515-9","volume":"31","author":"Freeman A.F.","year":"2011","unstructured":"Freeman A.F.; Avila E.M.; Shaw P.A.; Davis J.; Hsu A.P.; Welch P.; Matta J.R.; Hadigan C.; Pettigrew R.I.; Holland S.M.; Gharib A.M.; Coronary artery abnormalities in Hyper-IgE syndrome. J Clin Immunol  2011,31(3),338-345","journal-title":"J Clin Immunol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1177\/1538574418762656","volume":"52","author":"Sharma A.","year":"2018","unstructured":"Sharma A.; Kumar S.; Jagia P.; Pulmonary artery pseudoaneurysm in hyper-IgE syndrome: Rare complication with successful endovascular management. Vasc Endovascular Surg  2018,52(5),375-377","journal-title":"Vasc Endovascular Surg"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.placenta.2020.08.021","volume":"101","author":"Fang Y.","year":"2020","unstructured":"Fang Y.; Feng X.; Xue N.; Cao Y.; Zhou P.; Wei Z.; STAT3 signaling pathway is involved in the pathogenesis of miscarriage. Placenta  2020,101,30-38","journal-title":"Placenta"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/pai.12512","volume":"27","author":"Hagl B.","year":"2016","unstructured":"Hagl B.; Heinz V.; Schlesinger A.; Spielberger B.D.; Sawalle-Belohradsky J.; Senn-Rauh M.; Magg T.; Boos A.C.; H\u00f6nig M.; Schwarz K.; D\u00fcckers G.; von Bernuth H.; Pache C.; Karitnig-Weiss C.; Belohradsky B.H.; Frank J.; Niehues T.; Wahn V.; Albert M.H.; Wollenberg A.; Jansson A.F.; Renner E.D.; Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children. Pediatr Allergy Immunol  2016,27(2),177-184","journal-title":"Pediatr Allergy Immunol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jaci.2010.06.029","volume":"126","author":"Schimke L.F.","year":"2010","unstructured":"Schimke L.F.; Sawalle-Belohradsky J.; Roesler J.; Wollenberg A.; Rack A.; Borte M.; Rieber N.; Cremer R.; Maa\u00df E.; Dopfer R.; Reichenbach J.; Wahn V.; Hoenig M.; Jansson A.F.; Roesen-Wolff A.; Schaub B.; Seger R.; Hill H.R.; Ochs H.D.; Torgerson T.R.; Belohradsky B.H.; Renner E.D.; Diagnostic approach to the hyper-IgE syndromes: Immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol  2010,126(3),611-617.e1","journal-title":"J Allergy Clin Immunol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jaci.2009.10.059","volume":"125","author":"Woellner C.","year":"2010","unstructured":"Woellner C.; Gertz E.M.; Sch\u00e4ffer A.A.; Lagos M.; Perro M.; Glocker E.O.; Pietrogrande M.C.; Cossu F.; Franco J.L.; Matamoros N.; Pietrucha B.; Heropolita\u0144ska-Pliszka E.; Yeganeh M.; Moin M.; Espa\u00f1ol T.; Ehl S.; Gennery A.R.; Abinun M.; Br\u0119borowicz A.; Niehues T.; Kilic S.S.; Junker A.; Turvey S.E.; Plebani A.; S\u00e1nchez B.; Garty B.Z.; Pignata C.; Cancrini C.; Litzman J.; Sanal \u00d6.; Baumann U.; Bacchetta R.; Hsu A.P.; Davis J.N.; Hammarstr\u00f6m L.; Davies e.g.; Eren E.; Arkwright P.D.; Moilanen J.S.; Viemann D.; Khan S.; Mar\u00f3di L.; Cant A.J.; Freeman A.F.; Puck J.M.; Holland S.M.; Grimbacher B.; Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol  2010,125(2),424-432.e8","journal-title":"J Allergy Clin Immunol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jaci.2014.12.1945","volume":"136","author":"Engelhardt K.R.","year":"2015","unstructured":"Engelhardt K.R.; Gertz M.E.; Keles S.; Sch\u00e4ffer A.A.; Sigmund E.C.; Glocker C.; Saghafi S.; Pourpak Z.; Ceja R.; Sassi A.; Graham L.E.; Massaad M.J.; Mellouli F.; Ben-Mustapha I.; Khemiri M.; Kilic S.S.; Etzioni A.; Freeman A.F.; Thiel J.; Schulze I.; Al-Herz W.; Metin A.; Sanal \u00d6.; Tezcan I.; Yeganeh M.; Niehues T.; Dueckers G.; Weinspach S.; Patiroglu T.; Unal E.; Dasouki M.; Yilmaz M.; Genel F.; Aytekin C.; Kutukculer N.; Somer A.; Kilic M.; Reisli I.; Camcioglu Y.; Gennery A.R.; Cant A.J.; Jones A.; Gaspar B.H.; Arkwright P.D.; Pietrogrande M.C.; Baz Z.; Al-Tamemi S.; Lougaris V.; Lefranc G.; Megarbane A.; Boutros J.; Galal N.; Bejaoui M.; Barbouche M.R.; Geha R.S.; Chatila T.A.; Grimbacher B.; The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol  2015,136(2),402-412","journal-title":"J Allergy Clin Immunol"},{"key":"ref=88","year":"2019","unstructured":"ESID Registry-Working definitions for clinical diagnosis of PID. In: European Society of Immunodefeciencies.  Available from:  https:\/\/esid.org\/Working-Parties\/Registry-Working-Party\/Diagnosis-criteria (accessed December 20, 2022).2019"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s10875-013-9890-5","volume":"33","author":"Freeman A.F.","year":"2013","unstructured":"Freeman A.F.; Renner E.D.; Henderson C.; Langenbeck A.; Olivier K.N.; Hsu A.P.; Hagl B.; Boos A.; Davis J.; Marciano B.E.; Boris L.; Welch P.; Sawalle-Belohradsky J.; Belohradsky B.H.; Kwong K.F.; Holland S.M.; Lung parenchyma surgery in autosomal dominant hyper-IgE syndrome. J Clin Immunol  2013,33(5),896-902","journal-title":"J Clin Immunol"},{"key":"ref=90","first-page":"359","volume":"23","author":"Karakoc-Aydiner E.","year":"2013","unstructured":"Karakoc-Aydiner E.; Baris S.; Keles S.; Ozdemir C.; Chatila T.; Barlan I.; Inhaled alpha1-antitrypsin administered to treat pneumatocele in autosomal dominant hyperimmunoglobulin E syndrome. J Investig Allergol Clin Immunol  2013,23(5),359-361","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.clim.2014.04.005","volume":"153","author":"Al-Zahrani D.","year":"2014","unstructured":"Al-Zahrani D.; Raddadi A.; Massaad M.; Keles S.; Jabara H.H.; Chatila T.A.; Geha R.; Successful interferon-alpha 2b therapy for unremitting warts in a patient with DOCK8 deficiency. Clin Immunol  2014,153(1),104-108","journal-title":"Clin Immunol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0091-6749(95)70185-0","volume":"95","author":"Kimata H.","year":"1995","unstructured":"Kimata H.; High-dose intravenous \u03b3-globulin treatment for hyperimmunoglobulinemia E syndrome. J Allergy Clin Immunol  1995,95(3),771-774","journal-title":"J Allergy Clin Immunol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1081-1206(10)62802-5","volume":"81","author":"Wakim M.","year":"1998","unstructured":"Wakim M.; Alazard M.; Yajima A.; Speights D.; Saxon A.; Stiehm E.R.; High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome. Ann Allergy Asthma Immunol  1998,81(2),153-158","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.jaip.2019.01.033","volume":"7","author":"Pi\u00f1ones M.","year":"2019","unstructured":"Pi\u00f1ones M.; Vizcaya C.; P\u00e9rez-Mateluna G.; Hoyos-Bachiloglu R.; Borzutzky A.; Severe necrotic reaction to 23-valent polysaccharide pneumococcal vaccine in a patient with STAT3 deficiency. J Allergy Clin Immunol Pract  2019,7(5),1631-1632","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1097\/TP.0000000000002649","volume":"103","author":"Freeman A.F.","year":"2019","unstructured":"Freeman A.F.; Yazigi N.; Shah N.N.; Kleiner D.E.; Parta M.; Atkinson P.; Heller T.; Holland S.M.; Kaufman S.S.; Khan K.M.; Hickstein D.D.; Tandem orthotopic living donor liver transplantation followed by same donor haploidentical hematopoietic stem cell transplantation for DOCK8 deficiency. Transplantation  2019,103(10),2144-2149","journal-title":"Transplantation"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.det.2016.07.002","volume":"35","author":"Dimitrova D.","year":"2017","unstructured":"Dimitrova D.; Freeman A.F.; Current status of dedicator of cytokinesis-associated immunodeficiency. Dermatol Clin  2017,35(1),11-19","journal-title":"Dermatol Clin"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jaip.2018.10.035","volume":"7","author":"Aydin S.E.","year":"2019","unstructured":"Aydin S.E.; Freeman A.F.; Al-Herz W.; Al-Mousa H.A.; Arnaout R.K.; Aydin R.C.; Barlogis V.; Belohradsky B.H.; Bonfim C.; Bredius R.G.; Chu J.I.; Ciocarlie O.C.; Do\u011fu F.; Gaspar H.B.; Geha R.S.; Gennery A.R.; Hauck F.; Hawwari A.; Hickstein D.D.; Hoenig M.; Ikinciogullari A.; Klein C.; Kumar A.; Ifversen M.R.S.; Matthes S.; Metin A.; Neven B.; Pai S.Y.; Parikh S.H.; Picard C.; Renner E.D.; Sanal \u00d6.; Schulz A.S.; Schuster F.; Shah N.N.; Shereck E.B.; Slatter M.A.; Su H.C.; van Montfrans J.; Woessmann W.; Ziegler J.B.; Albert M.H.; Hematopoietic stem cell transplantation as treatment for patients with DOCK8 deficiency. J Allergy Clin Immunol Pract  2019,7(3),848-855","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0002-9343(98)00200-9","volume":"105","author":"Nester T.A.","year":"1998","unstructured":"Nester T.A.; Wagnon A.H.; Reilly W.F.; Spitzer G.; Kjeldsberg C.R.; Hill H.R.; Effects of allogeneic peripheral stem cell transplantation in a patient with Job syndrome of hyperimmunoglobulinemia E and recurrent infections. Am J Med  1998,105(2),162-164","journal-title":"Am J Med"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jaci.2010.05.005","volume":"126","author":"Goussetis E.","year":"2010","unstructured":"Goussetis E.; Peristeri I.; Kitra V.; Traeger-Synodinos J.; Theodosaki M.; Psarra K.; Kanariou M.; Tzortzatou-Stathopoulou F.; Petrakou E.; Fylaktou I.; Kanavakis E.; Graphakos S.; Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome. J Allergy Clin Immunol  2010,126(2),392-394","journal-title":"J Allergy Clin Immunol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10875-016-0278-1","volume":"36","author":"Yanagimachi M.","year":"2016","unstructured":"Yanagimachi M.; Ohya T.; Yokosuka T.; Kajiwara R.; Tanaka F.; Goto H.; Takashima T.; Morio T.; Yokota S.; The potential and limits of hematopoietic stem cell transplantation for the treatment of autosomal dominant hyper-IgE syndrome. J Clin Immunol  2016,36(5),511-516","journal-title":"J Clin Immunol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s10875-021-01051-1","volume":"41","author":"Tsilifis C.","year":"2021","unstructured":"Tsilifis C.; Freeman A.F.; Gennery A.R.; STAT3 Hyper-IgE syndrome : An update and unanswered questions. J Clin Immunol  2021,41(5),864-880","journal-title":"J Clin Immunol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ajhg.2014.05.007","volume":"95","author":"Stray-Pedersen A.","year":"2014","unstructured":"Stray-Pedersen A.; Backe P.H.; Sorte H.S.; M\u00f8rkrid L.; Chokshi N.Y.; Erichsen H.C.; Gambin T.; Elgst\u00f8en K.B.P.; Bj\u00f8r\u00e5s M.; Wlodarski M.W.; Kr\u00fcger M.; Jhangiani S.N.; Muzny D.M.; Patel A.; Raymond K.M.; Sasa G.S.; Krance R.A.; Martinez C.A.; Abraham S.M.; Speckmann C.; Ehl S.; Hall P.; Forbes L.R.; Merckoll E.; Westvik J.; Nishimura G.; Rustad C.F.; Abrahamsen T.G.; R\u00f8nnestad A.; Osnes L.T.; Egeland T.; R\u00f8dningen O.K.; Beck C.R.; Boerwinkle E.A.; Gibbs R.A.; Lupski J.R.; Orange J.S.; Lausch E.; Hanson I.C.; PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia. Am J Hum Genet  2014,95(1),96-107","journal-title":"Am J Hum Genet"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10875-021-01196-z","volume":"42","author":"Winslow A.","year":"2022","unstructured":"Winslow A.; Jalazo E.R.; Evans A.; Winstead M.; Moran T.; A De Novo cause of PGM3 deficiency treated with hematopoietic stem cell transplantation. J Clin Immunol  2022,42(3),691-694","journal-title":"J Clin Immunol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"835257","DOI":"10.3389\/fmed.2022.835257","volume":"9","author":"Lan J.","year":"2022","unstructured":"Lan J.; Zhang Y.; Song M.; Cai S.; Luo H.; OuYang R.; Yang P.; Shi X.; Long Y.; Chen Y.; Omalizumab for STAT3 Hyper-IgE syndromes in adulthood: A case report and literature review. Front Med  2022,9,835257","journal-title":"Front Med"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6357256","volume":"2019","author":"Alonso-Bello C.D.","year":"2019","unstructured":"Alonso-Bello C.D.; Jim\u00e9nez-Mart\u00ednez M.C.; Vargas-Cama\u00f1o M.E.; Hierro-Orozco S.; Ynga-Durand M.A.; Berr\u00f3n-Ruiz L.; Alc\u00e1ntara-Montiel J.C.; Santos-Argumedo L.; Herrera-S\u00e1nchez D.A.; Lozano-Pati\u00f1o F.; Castrej\u00f3n-V\u00e1zquez M.I.; Partial and transient clinical response to omalizumab in IL-21-induced low STAT3-phosphorylation on hyper-IgE syndrome. Case Reports Immunol  2019,2019,1-5","journal-title":"Case Reports Immunol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1001\/archdermatol.2008.510","volume":"144","author":"Bard S.","year":"2008","unstructured":"Bard S.; Paravisini A.; Avil\u00e9s-Izquierdo J.A.; Fernandez-Cruz E.; S\u00e1nchez-Ram\u00f3n S.; Eczematous dermatitis in the setting of hyper-IgE syndrome successfully treated with omalizumab. Arch Dermatol  2008,144(12),1662-1663","journal-title":"Arch Dermatol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"191","DOI":"10.18176\/jiaci.0469","volume":"30","author":"Gomes N.","year":"2020","unstructured":"Gomes N.; Miranda J.; Lopes S.; Carneiro-Le\u00e3o L.; Torres Costa J.; Baudrier T.; Azevedo F.; Omalizumab in the treatment of hyper-IgE syndrome: 2 case reports. J Investig Allergol Clin Immunol  2020,30(3),191-192","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"e13770","DOI":"10.1111\/pai.13770","volume":"33","author":"Matucci-Cerinic C.","year":"2022","unstructured":"Matucci-Cerinic C.; Viglizzo G.; Pastorino C.; Corcione A.; Prigione I.; Bocca P.; Bustaffa M.; Cecconi M.; Gattorno M.; Volpi S.; Remission of eczema and recovery of Th1 polarization following treatment with Dupilumab in STAT3 hyper IgE syndrome. Pediatr Allergy Immunol  2022,33(4),e13770","journal-title":"Pediatr Allergy Immunol"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s10875-020-00751-4","volume":"40","author":"L\u00e9vy R.","year":"2020","unstructured":"L\u00e9vy R.; B\u00e9ziat V.; Barbieux C.; Puel A.; Bourrat E.; Casanova J.L.; Hovnanian A.; Efficacy of dupilumab for controlling severe atopic dermatitis in a patient with hyper-IgE syndrome. J Clin Immunol  2020,40(2),418-420","journal-title":"J Clin Immunol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1385\/CRIAI:20:1:139","volume":"20","author":"Buckley R.H.","year":"2001","unstructured":"Buckley R.H.; The hyper-IgE syndrome. Clin Rev Allergy Immunol  2001,20(1),139-154","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"e12885","DOI":"10.1111\/sji.12885","volume":"91","author":"Xiang Q.","year":"2020","unstructured":"Xiang Q.; Zhang L.; Liu X.; Wang S.; Wang T.; Xiao M.; Zhao X.; Jiang L.; Autosomal dominant hyper IgE syndrome from a single centre in Chongqing, China (2009-2018). Scand J Immunol  2020,91(6),e12885","journal-title":"Scand J Immunol"}],"container-title":["Current Pediatric Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573396320666230912103124","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/220940\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573396320666230912103124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T14:50:26Z","timestamp":1707749426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/220940\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":111,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573396320666230912103124","relation":{},"ISSN":["1573-3963"],"issn-type":[{"value":"1573-3963","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-06-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}